Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carfilzomib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01857115
What this trial is testing

Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 63
Large-scale testing (Phase 3)Study completedNCT01302392
What this trial is testing

Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 315
Not applicableUnknownNCT04004338
What this trial is testing

Carfilzomib in Combination for the Treatment of RR MM

Who this might be right for
Multiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma
Black Sea Hematology Association 300
Testing effectiveness (Phase 2)UnknownNCT03336073
What this trial is testing

Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 199
Testing effectiveness (Phase 2)Study completedNCT04191616
What this trial is testing

Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Amgen 54
Early research (Phase 1)Study completedNCT02303821
What this trial is testing

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)
Amgen 141
Testing effectiveness (Phase 2)Active Not RecruitingNCT03673826
What this trial is testing

Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM

Who this might be right for
Smouldering Myeloma
Stichting Hemato-Oncologie voor Volwassenen Nederland 58
Testing effectiveness (Phase 2)Study completedNCT00531284
What this trial is testing

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Who this might be right for
Ovarian CancerRenal CancerNon-small Cell Lung Cancer+4 more
Amgen 184
Testing effectiveness (Phase 2)Study completedNCT02597062
What this trial is testing

High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Canadian Cancer Trials Group 76
Testing effectiveness (Phase 2)Study completedNCT01365559
What this trial is testing

Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments

Who this might be right for
Multiple Myeloma
Oncotherapeutics 39
Not applicableUnknownNCT05184595
What this trial is testing

Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib

Who this might be right for
Multiple Myeloma
Central Hospital, Nancy, France 52
Early research (Phase 1)Looking for participantsNCT06918990
What this trial is testing

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

Who this might be right for
Kidney Transplant Rejection
National Institute of Allergy and Infectious Diseases (NIAID) 25
Large-scale testing (Phase 3)Study completedNCT03158688
What this trial is testing

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Amgen 466
Testing effectiveness (Phase 2)Study completedNCT01665794
What this trial is testing

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Chicago 25
Early research (Phase 1)Study completedNCT01212380
What this trial is testing

Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaHematopoietic/Lymphoid CancerProlymphocytic Leukemia+2 more
Ohio State University Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT01677858
What this trial is testing

Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 116
Early research (Phase 1)Study completedNCT01980589
What this trial is testing

A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects

Who this might be right for
Multiple Myeloma
Amgen 22
Testing effectiveness (Phase 2)Study completedNCT01402284
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04268498
What this trial is testing

Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Miami 310
Not applicableStudy completedNCT03375567
What this trial is testing

Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone

Who this might be right for
Multiple Myeloma
Yale University 28
Next Page